Article Information
History
- September 25, 2020.
Article Versions
- Version 1 (September 18, 2020 - 13:45).
- Version 2 (September 19, 2020 - 23:36).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Albert Prats-Uribe, MD, MPH1,*,
- Anthony G. Sena, BA2,3,*,
- Lana Yin Hui Lai, PhD4,
- Waheed-Ul-Rahman Ahmed5,6,
- Heba Alghoul, MD7,
- Osaid Alser, MD, MSc8,
- Thamir M Alshammari9,
- Carlos Areia10,
- William Carter, MCIS32,
- Paula Casajust11,
- Dalia Dawoud12,
- Asieh Golozar14,15,
- Jitendra Jonnagaddala16,
- Paras P. Mehta31,
- Mengchun Gong, MD17,
- Daniel R. Morales18,
- Fredrik Nyberg, MD, PhD30,
- Jose D. Posada19,
- Martina Recalde20,21,
- Elena Roel, MD, MPH20,
- Karishma Shah, MBBS5,
- Nigam H. Shah, MBBS, PhD19,
- Lisa M. Schilling, MD, MSPH32,
- Vignesh Subbian22,
- David Vizcaya23,
- Andrew Williams,
- Lin Zhang24,25,
- Ying Zhang, PhD17,
- Hong Zhu, PhD26,
- Li Liu, MD26,
- Peter Rijnbeek3,
- George Hripcsak27,
- Jennifer CE Lane, MRCS1,
- Edward Burn1,20,
- Christian Reich, MD, PhD28,
- Marc A. Suchard29,
- Talita Duarte-Salles, PhD9,
- Kristin Kostka, MPH28,
- Patrick Ryan2,27,§ and
- Daniel Prieto-Alhambra1
- 1Pharmaco- and Device Epidemiology, Centre for Statistics in Medicine - Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, UK
- 2Janssen Research and Development, Titusville, NJ, USA
- 3Department of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands
- 4Division of Cancer Sciences, School of Medical Sciences, University of Manchester
- 5Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, OX3 7LD, UK
- 6College of Medicine and Health, University of Exeter, St Luke’s Campus, Heavitree Road, Exeter, EX1 2LU, UK
- 7Faculty of Medicine, Islamic University of Gaza, Palestine
- 8Massachusetts General Hospital, Harvard Medical School, Boston, 02114, Massachusetts, USA
- 9Medication Safety Research Chair, King Saud University, Riyadh, Saudi Arabia
- 10Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
- 11Real-World Evidence, Trial Form Support, Barcelona, Spain
- 12Cairo University, Faculty of Pharmacy, Cairo, Egypt
- 14Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 15Regeneron Pharmaceuticals, Tarrytown, NY, US
- 16School of Public Health and Community Medicine, UNSW Sydney
- 17DHC Technologies Co. Ltd, Beijing, China
- 18Division of Population Health and Genomics, University of Dundee, UK
- 19Stanford University School of Medicine, Stanford, California, USA
- 20Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
- 21Universitat Autònoma de Barcelona, Spain
- 22College of Engineering, The University of Arizona, Tucson, AZ, USA
- 23Bayer Pharmaceuticals, Sant Joan Despí, Spain
- 24School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College
- 25School of Population and Global Health, The University of Melbourne
- 26Nanfang Hospital, Southern Medical University, Guangzhou, China
- 27Department of Biomedical Informatics, Columbia University Irving Medical Center, New York, NY, USA
- 28Real World Solutions, IQVIA, 201 Broadway # 5, Cambridge, MA 02139 USA
- 29Department of Biostatistics, UCLA Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA
- 30School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
- 31College of Medicine, The University of Arizona, Tucson, AZ, USA
- 32Data Science to Patient Value Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
- 33Tufts Institute for Clinical Research and Health Policy Studies, Boston, MA, 02111, USA
- ↵§Corresponding author: Patrick Ryan, Janssen Research & Development, Titusville, NJ, USA, ryan{at}ohdsi.org, +919.609.2723
Posted September 25, 2020.
Heterogeneity and temporal variation in the management of COVID-19: a multinational drug utilization study including 71,921 hospitalized patients from China, South Korea, Spain, and the United States of America
